Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand?

Pulmonary arterial hypertension, a disease largely neglected until a few decades ago, is presently the object of intense studies by several research teams. Despite considerable progress, pulmonary arterial hypertension remains a major clinical problem, because it is not always easy to diagnose, trea...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Vasc Health Risk Manag
Egile Nagusiak: Correale, Michele, Ferraretti, Armando, Monaco, Ilenia, Grazioli, Davide, Di Biase, Matteo, Brunetti, Natale Daniele
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2018
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6174907/
https://ncbi.nlm.nih.gov/pubmed/30323613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S133921
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak